The content is available as a PDF (253.9 KB).
letter . 2021 Sep 17:ciab816. doi: 10.1093/cid/ciab816
Outcome heterogeneity in COVID-19 patients receiving tocilizumab
Man Man Niu
1, Yue Cao
1, Rui Xue Li
1, Guo Zhen Fan
1, Peng Hu
1,✉
Man Man Niu
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
Find articles by Man Man Niu
Yue Cao
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
Find articles by Yue Cao
Rui Xue Li
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
Find articles by Rui Xue Li
Guo Zhen Fan
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
Find articles by Guo Zhen Fan
Peng Hu
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
Find articles by Peng Hu
1Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, PR China
✉
Corresponding author: Peng Hu, MD, PhD, Department of Pediatrics, the First Affiliated Hospital of Anhui Medical University, No. 218 Ji-Xi Road, Hefei, Anhui Province, 230022, PR China, Tel: +86 0551 62922058 Fax: none E-mail: hupeng28@aliyun.com
Received 2021 Sep 6.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC8499993 PMID: 34534286